Current Clinical Trials
Gastrointestinal and Genitourinary cancer research
To inquire about ongoing gastrointestinal and genitourinary cancer clinical trials, please reach the clinical research team on 01-350000 Ext: 5110, 7804 or 7803
Ongoing gastrointestinal and genitourinary cancer clinical trials:
Bladder cancer:
-
Bio-2019-0435: FREYR: Multicentre Cross-sectional Study to Assess the Frequency of FGFR alterations in patients with Urothelial Carcinoma in the Middle East, North Africa, and Russia
- A phase II, randomized, non-comparative double arm, open label, 2-stage, multicenter trial to evaluate the efficacy and safety of Tetra-modality bladder preservation strategies in muscle-invasive bladder cancer with maximum TURBT followed by induction platinum-based chemotherapy/Avelumab followed by radiation therapy then maintenance Avelumab or watch and wait approach
Prostate cancer:
PI Dr. Ali Shamseddine:
- Bio-2018-0538: Multi-Center, Observational, Retrospective Study of Prostate Cancer in Real Practice within Middle Eastern and North African Countries – Patients’ Characterization, Disease Prognosis and Treatment Patterns in Prostate Cancer in Real Practice in the Middle East and North Africa (PROCARE)
Colorectal cancer:
Dr. Ali Shamseddine:
- Bio-2017-0422: Short-course radiation followed by mfolfox-6 plus Avelumab for locally-advanced rectal adenocarcinoma (2018)
QUICK LINKS
